| Net Cash Provided by (Used in) Operating Activities |
$141,257,000 |
USD |
52% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$197,560,000 |
USD |
99% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$345,009,000 |
USD |
-87% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
108,921,356 |
shares |
21% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,192,000 |
USD |
-178% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$39,984,000 |
USD |
143% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$52,333,000 |
USD |
7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$336,389,000 |
USD |
-0.6% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$176,567,000 |
USD |
6.9% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$15,366,000 |
USD |
38% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$618,000 |
USD |
-91% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$31,592,000 |
USD |
88% |
Q4 2024 |
FY 2024 |
| Operating Lease, Payments |
$5,145,000 |
USD |
34% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$114,300,000 |
USD |
11% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$70,149,000 |
USD |
18% |
Q3 2025 |
Q3 2025 |